Literature DB >> 6759144

Comparative effects of alinidine and propranolol in ischaemic heart disease.

J Schurmans, J Piessens, H Kesteloot, H De Geest.   

Abstract

The effects of single oral doses of alinidine 40 mg, propranolol 40 mg or placebo during a maximal exercise test on a bicycle ergometer in patients with angina pectoris were studied in a randomised, double blind study. 2 and 5 h after drug intake a small fall in resting heart rate and systolic blood pressure was observed both after alinidine and propranolol. At a fixed work load both drugs decreased heart rate, systolic blood pressure, double product and the extent of ST segment depression. Total work performed and time to appearance of angina pectoris were increased 2 h alinidine and propranolol. The same effects were still apparent 5 h after propranolol but not after alinidine. At peak exercise neither drug had any effect on the extent of ischaemic ST segment depression.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6759144     DOI: 10.1007/bf00605987

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  14 in total

1.  Diagnostic value of clinical history, exercise testing and atrial pacing in patients with chest pain.

Authors:  J Piessens; W Van Mieghem; H Kesteloot; H De Geest
Journal:  Am J Cardiol       Date:  1974-03       Impact factor: 2.778

2.  Anion antagonism--a fifth class of antiarrhythmic action?

Authors:  J S Millar; E M Williams
Journal:  Lancet       Date:  1981-06-13       Impact factor: 79.321

3.  Cardiovascular actions of N-allyl-clonidine (ST 567), a substance with specific bradycardic action.

Authors:  W Kobinger; C Lillie; L Pichler
Journal:  Eur J Pharmacol       Date:  1979-09-15       Impact factor: 4.432

4.  Relation of heart rate and systolic blood pressure to the onset of pain in angina pectoris.

Authors:  B F Robinson
Journal:  Circulation       Date:  1967-06       Impact factor: 29.690

5.  [Hemodynamic actions on alinidine during exercise in patients with coronary artery disease].

Authors:  H Löllgen; H Just; H Wollschläger; F Kersting
Journal:  Z Kardiol       Date:  1981-05

6.  Pharmacokinetic and pharmacodynamic properties of alinidine in man.

Authors:  U W Wiegand; W Kasper; T Meinertz; U Stützle; E Jähnchen
Journal:  J Cardiovasc Pharmacol       Date:  1982 Jan-Feb       Impact factor: 3.105

7.  Pacemaker selectivity: influence on rabbit atria of ionic environment and of alinidine, a possible anion antagonist.

Authors:  J S Millar; E M Williams
Journal:  Cardiovasc Res       Date:  1981-06       Impact factor: 10.787

8.  The effects of alinidine, an N-allyl derivative of clonidine, on regional myocardial perfusion and performance in the pig with or without atrial pacing.

Authors:  P D Verdouw; P R Saxena; H C Schamhardt; T M van der Hoek; A M Rutteman
Journal:  Eur J Pharmacol       Date:  1980-06-27       Impact factor: 4.432

9.  Haemodynamic and electrophysiologic actions of alinidine in the dog.

Authors:  W Traunecker; A Walland
Journal:  Arch Int Pharmacodyn Ther       Date:  1980-03

10.  Alinidine reduces heart-rate without blockade of beta-adrenoceptors.

Authors:  D W Harron; J G Riddell; R G Shanks
Journal:  Lancet       Date:  1981-02-14       Impact factor: 79.321

View more
  2 in total

1.  Effect of the combination of alinidine and other anti-anginal drugs on heart rate and blood pressure in healthy volunteers.

Authors:  D W Harron; A H Deering; M Scott; M McMahon; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1989-01       Impact factor: 4.335

2.  Exercise tolerance in angina is improved by mivazerol--an alpha 2-adrenoceptor agonist.

Authors:  R A Wright; P Decroly; T Kharkevitch; M F Oliver
Journal:  Cardiovasc Drugs Ther       Date:  1993-12       Impact factor: 3.727

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.